Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cantor Fitzgerald
US Army
Johnson and Johnson
Argus Health

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,422,369

« Back to Dashboard

Title: Prostaglanddin derivatives for the treatment of glaucoma or ocular hypertension
Abstract:This invention relates a method for topical treatment of glaucoma or ocular hypertension by administration of an effective intraocular pressure reducing amont of a prostaglandin derivative of PGA, PGB, PGE and PGF, in which the omega chain contains a ring structure. The invention further relates to compositions comprising said prostaglandin derivatives in an ophthalmologically compatible carrier.
Inventor(s): Stjernschantz; Johan W. (Uppsala, SE), Resul; Bahram (Uppsala, SE)
Assignee: Kabi Pharmacia AB (Uppsala, SE)
Filing Date:Feb 25, 1994
Application Number:08/202,409
Claims:1. A therapeutic composition for topical treatment of ocular hypertension or glaucoma comprising a therapeutically effective amount of the isopropyl ester of 13,14-dihydro-15-dehydro-17-phenyl-18,19,20-trinor-PGF.sub.2.alpha. in a pharmaceutically acceptable carrier.

2. A method of treating ocular hypertension or glaucoma by topical application of a composition of claim 1.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cantor Fitzgerald
Argus Health
Express Scripts
US Department of Justice
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.